Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral Suppressors
|
journal
|
January 2009 |
Activation of NK Cells by ADCC Antibodies and HIV Disease Progression
|
journal
|
January 2011 |
Solving structures of protein complexes by molecular replacement with Phaser
|
journal
|
December 2006 |
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
|
journal
|
May 1997 |
Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro
|
journal
|
September 2001 |
Recombinant gp120 Vaccine-Induced Antibodies Inhibit Clinical Strains of HIV-1 in the Presence of Fc Receptor-Bearing Effector Cells and Correlate Inversely with HIV Infection Rate
|
journal
|
May 2007 |
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein
|
journal
|
July 2012 |
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
|
journal
|
June 2009 |
CD4-Induced Epitopes in the HIV Envelope Glycoprotein, Gp120
|
journal
|
November 2007 |
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
|
journal
|
April 2012 |
Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4
|
journal
|
September 2007 |
Antibody-Dependent Cell-Mediated Cytotoxicity in Simian Immunodeficiency Virus-Infected Rhesus Monkeys
|
journal
|
May 2011 |
Structure of a V3-Containing HIV-1 gp120 Core
|
journal
|
November 2005 |
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection
|
journal
|
February 2009 |
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
|
journal
|
June 1998 |
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
|
journal
|
October 2010 |
Correlation Between Circulating HIV-1 RNA and Broad HIV-1 Neutralizing Antibody Activity
|
journal
|
January 2011 |
MrBUMP : an automated pipeline for molecular replacement
|
journal
|
December 2007 |
Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure
|
journal
|
April 2011 |
Activation of NK Cells by ADCC Responses During Early HIV Infection
|
journal
|
April 2011 |
Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1
|
journal
|
January 1991 |
Improved Breadth and Potency of an HIV-1-Neutralizing Human Single-chain Antibody by Random Mutagenesis and Sequential Antigen Panning
|
journal
|
January 2004 |
Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1
|
journal
|
September 2003 |
FcγRIIa Genotype Predicts Progression of HIV Infection
|
journal
|
November 2007 |
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens
|
journal
|
October 2007 |
Canonical structures for the hypervariable regions of immunoglobulins
|
journal
|
August 1987 |
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility
|
journal
|
December 2009 |
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.
|
journal
|
November 1990 |
The CCP4 suite programs for protein crystallography
|
journal
|
September 1994 |
Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 Proteins
|
journal
|
October 2011 |
Rational antibody-based HIV-1 vaccine design: current approaches and future directions
|
journal
|
June 2010 |
In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity
|
journal
|
November 1998 |
Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines
|
journal
|
March 2009 |
Sustained Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in SIV-Infected Macaques Correlates with Delayed Progression to AIDS
|
journal
|
November 2002 |
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
|
text
|
January 2009 |
Expression and Characterization of a Single-Chain Polypeptide Analogue of the Human Immunodeficiency Virus Type 1 gp120-CD4 Receptor Complex
|
journal
|
December 2000 |
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Antigenic Properties of the Human Immunodeficiency Virus Transmembrane Glycoprotein during Cell-Cell Fusion
|
journal
|
December 2002 |
Vaccine-Elicited Antibodies Mediate Antibody-Dependent Cellular Cytotoxicity Correlated with Significantly Reduced Acute Viremia in Rhesus Macaques Challenged with SIV mac251
|
journal
|
February 2005 |
Structural evidence for substrate strain in antibody catalysis
|
journal
|
January 2003 |
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
|
journal
|
January 1999 |
Fc receptor but not complement binding is important in antibody protection against HIV
|
journal
|
September 2007 |
Purified, Proteolytically Mature HIV Type 1 SOSIP gp140 Envelope Trimers
|
journal
|
June 2007 |
Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding
|
journal
|
November 2000 |
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
|
journal
|
May 2005 |
Determination of a Statistically Valid Neutralization Titer in Plasma That Confers Protection against Simian-Human Immunodeficiency Virus Challenge following Passive Transfer of High-Titered Neutralizing Antibodies
|
journal
|
March 2002 |
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection
|
journal
|
February 2000 |
The antigenic structure of the HIV gp120 envelope glycoprotein
|
journal
|
June 1998 |
HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
|
journal
|
June 2012 |
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
|
journal
|
February 2004 |
Dependence of the chemical nature of antibodies on the net electrical charge of antigens.
|
journal
|
February 1966 |
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library
|
journal
|
December 2003 |
Characterization of CD4-Induced Epitopes on the HIV Type 1 gp120 Envelope Glycoprotein Recognized by Neutralizing Human Monoclonal Antibodies
|
journal
|
November 2002 |
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity
|
journal
|
January 2006 |
Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus
|
journal
|
June 2002 |
Exploring the gas access routes in a [NiFeSe] hydrogenase using crystals pressurized with krypton and oxygen
|
journal
|
August 2020 |
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
|
journal
|
January 1995 |
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
|
journal
|
March 2009 |
Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
|
journal
|
September 2002 |
Antibodies Mediating Cellular Cytotoxicity and Neutralization Correlate with a Better Clinical Stage in Children Born to Human Immunodeficiency Virus-Infected Mothers
|
journal
|
February 1990 |
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
|
journal
|
November 2009 |
Joint X-ray and neutron refinement with phenix.refine
|
journal
|
October 2010 |
Long-term Nonprogressive Disease Among Individuals With Untreated HIV Infection
|
journal
|
October 2010 |
Multiple Vaccine-Elicited Nonneutralizing Antienvelope Antibody Activities Contribute to Protective Efficacy by Reducing both Acute and Chronic Viremia following Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques
|
journal
|
May 2010 |
Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains
|
journal
|
October 2003 |
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
Topological Layers in the HIV-1 gp120 Inner Domain Regulate gp41 Interaction and CD4-Triggered Conformational Transitions
|
journal
|
March 2010 |
Antigenic Properties of the Human Immunodeficiency Virus Envelope during Cell-Cell Fusion
|
journal
|
November 2001 |
Synergistic Neutralization of a Chimeric SIV/HIV Type 1 Virus with Combinations of Human Anti-HIV Type 1 Envelope Monoclonal Antibodies or Hyperimmune Globulins
|
journal
|
May 1997 |
Crystal Structure of the Broadly Cross-Reactive HIV-1-Neutralizing Fab X5 and Fine Mapping of Its Epitope † , ‡
|
journal
|
February 2004 |
Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development
|
journal
|
November 2003 |
Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site
|
journal
|
May 2009 |
Challenges of antibody-mediated protection against HIV-1
|
journal
|
July 2010 |
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
|
journal
|
July 2012 |
Antibody‐Dependent Cellular Cytotoxicity Independently Predicts Survival in Severely Immunocompromised Human Immunodeficiency Virus–Infected Patients
|
journal
|
October 1999 |
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
|
journal
|
May 2002 |
Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques
|
journal
|
October 2008 |
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1
|
journal
|
January 1989 |
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.
|
journal
|
January 1997 |
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
|
journal
|
January 1993 |
Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.
|
journal
|
January 1994 |
Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1.
|
journal
|
January 1994 |
Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.
|
journal
|
January 1996 |
Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.
|
journal
|
January 1997 |
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
|
journal
|
August 2012 |
HIV-1 natural viral suppressors: control of viral replication in the absence of therapy
|
journal
|
January 2007 |
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
|
journal
|
January 1994 |
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
|
text
|
January 2010 |
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
|
text
|
January 2000 |